Loading…
EQT Life Sciences announced that AbbVie and iSTAR Medical entered a strategic transaction to further develop and commercialize iSTAR Medical's MINIject device, a minimally invasive glaucoma surgical device. Deal terms include a $60 million upfront payment to iSTAR Medical.